Candidate of Medicine (Latin: Candidatus Medicinae (male), Candidata Medicinae (female), abbreviated Cand. Med.) is an academic degree awarded in Denmark, Iceland and Norway following a six-year medical school education.
The degree can also be written as Candidatus/Candidata Medicinæ (Æ instead of AE). In Danish and Norwegian, the degree is, similar to other Latin degrees, generally not capitalized (i.e. it's written as candidatus/candidata medicinae and abbreviated cand. med.). The Latin term or its abbreviation are always used, i.e. they are not translated.
The term candidate refers to those running for public office in Ancient Rome. Traditionally, many doctors (and lawyers) in Denmark and Norway would hold positions directly appointed by the King.
In Denmark and Norway, a research doctorate or a higher doctorate of medicine is known as Dr. Med. (Doctor Medicinae, literally, Doctor of Medicine). In order to be allowed to defend a Dr. Med. thesis, one must hold a Cand. Med. degree. In Denmark, there are currently two research doctorates that can be obtained in the field of medicine, the PhD (the smaller doctorate) and the Dr. Med. (the higher doctorate). Dr. Med. was abolished in Norway in 2008 and replaced by the PhD and the Dr. Philos.
In Norway the education is offered at the Norwegian University of Science and Technology, University of Bergen, University of Oslo and University of Tromsø. Following the education, candidates are permitted to work as rotation doctor, first at a hospital for one year and then six months as a general practitioner. After the rotation service, the candidate may receive formal qualifications as a medical practitioner.
The first Norwegian to receive this degree was Carl Schultz in 1817. Along with the cand.med.vet., cand.psychol. and cand.theol. it is one of the few Latin titles to survive the "Quality Reform" in Norway.
In Germany and Switzerland, the term cand. med. is commonly used to denote a medical student in a six-year program who has passed the First Medical State Examination after two years of pre-clinical study and has entered the clinical part.
|
|||||